Key Influencer in the Cell Therapy Market 2025: The Soaring Prevalence Of Chronic Diseases Fuels Expansion In The Cell Therapy Market Driver

What combination of drivers is leading to accelerated growth in the cell therapy market?
The escalation in chronic diseases has fueled the growth of the cell therapy market. The US Centers for Disease Control and Prevention (CDC) defines chronic disease as a condition that lasts longer than a year, requiring medical care, restricting daily activities, or both, encompassing illnesses like heart disease, cancer, diabetes, and Parkinson's disease. Stem cells offer potential benefits to patients battling conditions like spinal cord injuries, type 1 diabetes, Parkinson's disease (PD), heart disease, cancer, and osteoarthritis. For instance, in July 2024, significant updates were made public regarding health initiatives by the Centers for Disease Control and Prevention (CDC), a national public health agency based in the U.S. Each year, heart disease or stroke claims more than 944,800 American lives, constituting over a third of all death occurrences. Annually, about 1.7 million Americans receive a cancer diagnosis, with over 600,000 of them dying, making it the second leading death-causing disease. More so, over 38 million Americans live with diabetes, and an additional 98 million adults are prediabetic, heightening their chances of developing type 2 diabetes. Diabetes has severe implications like heart disease, kidney failure, and even blindness. With 20% of children and 42% of adults experiencing obesity, the risk of chronic diseases like type 2 diabetes, heart disease, and certain cancers rises. The escalating incidence of chronic diseases has elevated the need for cell therapies, facilitating the growth of the cell therapy market.

Get Your Cell Therapy Market Report Here:
https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

What is the projected compound annual growth rate (CAGR) of the cell therapy market from 2025 to 2034, and what factors influence it?
The size of the cell therapy market has expanded at an accelerated pace in recent years. The market is projected to swell from $14.56 billion in 2024 to $17.02 billion in 2025, signaling a compound annual growth rate (CAGR) of 16.9%. The enlargement recorded in the historical period is due to factors such as initial research and findings, regulatory achievements, clinical experiments and investigations, early innovators and leading companies, along with market approval and perception.

The market size for cell therapy is projected to experience a swift expansion in the upcoming years. The market value is forecasted to reach $29.28 billion in 2029, growing at a compound annual growth rate (CAGR) of 14.5%. This surge in the predicted period could be credited to ethical and societal factors, trends in investment and funding, demand from consumers or patients, healthcare infrastructure, and fast-paced innovation cycles. Key trends anticipated during this forecast period encompass personalized medicine, the advent of targeted treatments, advancements in gene editing technologies, the broadening of stem cell research, progress in immunotherapy, and manipulation of the microenvironment.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp

How are the latest trends influencing the growth of the cell therapy market?
Major market participants are actively engaging in strategic partnerships and collaborations to broaden their range of products and their global footprint. Ajinomoto Co Inc., a food enterprise from Japan, procured Forge Biologics in November 2023 for $620 million. The acquisition is part of Ajinomoto Co Inc.'s strategy to strengthen its worldwide competence in AAV and plasmid gene therapy production, thus enhancing and solidifying its current contract development and manufacturing services. Forge Biologics, a biotech firm based in the US, is dedicated to promoting cell therapy technologies for treating a variety of illnesses.

What are the major segments of the cell therapy market and their role in driving growth?
The cell therapy market covered in this report is segmented -

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy
2) By Therapy Type: Allogeneic Therapies, Autologous Therapies
3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications

Subsegments:
1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy
2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine
3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy
4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy
5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3393

Which regions are key players in the growth of the cell therapy market?
North America was the largest region in the cell therapy market in 2024. The regions covered in the cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the key firms paving the way for growth in the cell therapy market?
Major companies operating in the cell therapy market include Celgene Corporation, JCR Pharmaceuticals Co. Ltd., Baxter Healthcare Corporation, Nipro Corp., Stempeutics Research Pvt. Ltd., Osiris Therapeutics Inc., Vericel Corporation, AlloSource, Anterogen Co. Ltd., Arteriocyte Medical Systems Inc., MediPost Co. Ltd., Pharmicell Co. Ltd., Corestem Inc., Stemedica Cell Technologies Inc., Adaptimmune Therapeutics plc, Mesoblast Ltd., Cell Medica Ltd., Cellerant Therapeutics Inc., Kolon TissueGene Inc., Tego Science Inc., Athersys Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Forticell Bioscience Inc., Bone Therapeutics, Holostem Terapie Avanzate S.r.l, Fibrocell Science Inc., AlloCure Inc., TiGenix NV, Cells for Cells, AVROBIO Inc., Cellular Biomedicine Group Inc., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Charles River Laboratories International Inc., Lonza Group Ltd., Catalent Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp

What Is Covered In The Cell Therapy Global Market Report?

• Market Size Forecast: Examine the cell therapy market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the cell therapy market for a structured understanding.
• Key Players Overview: Analyze major players in the cell therapy market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the cell therapy market.
• Segment Contributions: Evaluate how different segments drive overall growth in the cell therapy market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the cell therapy market.
• Industry Challenges: Identify potential risks and obstacles affecting the cell therapy market.
• Competitive Landscape: Review strategic developments in the cell therapy market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.